M. Penner et al., PREDEPOSIT OF AUTOLOGOUS BLOOD AND ISOVOL AEMIC HEMODILUTION - INDICATIONS AND PRACTICAL IMPLICATIONS, Infusionstherapie und Transfusionsmedizin, 20(6), 1993, pp. 307-315
Objective: The state of the art of autologous blood transfusion is des
cribed with special emphasis on safety aspects, indications and medico
legal implications. Data Sources and Selection Criteria: Literature wa
s retrieved using the MEDLINE literature database. Medical and legal e
xpert opinions on autologous blood transfusion programmes are presente
d as well as the actual German jurisdiction. Guidelines for autologous
predeposit and haemodilution used in the University of Munster are de
scribed. Results: In the past decade all forms of autologous transfusi
ons gained increasing influence in haemotherapy due to the ongoing dis
cussion on the safety of blood products. The German Federal Court has
demanded that whenever homologous perioperative transfusion is conside
red likely, patients have to be offered autologous predeposit. Legal c
onditions for autologous programmes directed by anaesthetists not spec
ialised in transfusion medicine are described. Whole-blood predeposit
should be limited to two autologous units. In cases with minor blood l
oss, isovolaemic haemodilution may be performed instead of autologous
predeposit. However, autologous transfusions have their specific risks
that are either related to the patient or to the procedure of autolog
ous predeposit, e.g., clerical error, contamination of blood products
and technical faults. Standard procedures of the University of Munster
to ensure low-risk autologous transfusion are presented. They consist
in adequate handling and proper identification, testing of donor for
virus infection markers, bacterial culture from blood products and a l
ist of contraindications: anaemia, unstable angina, myocardial infarct
ion within 3 months, decompensated heart insufficiency, aortic valve s
tenosis with angina, and cases with infection and fever. Conclusion: T
he risks related with autologous transfusion should be lower compared
to homologous transfusions. Well-defined standards concerning indicati
ons and techniques are required to reach this goal.